Risankizumab, guselkumab, and ustekinumab were associated with the lowest risk for progression from psoriasis to psoriatic arthritis.
DEFUSCO, WGAL NEWS EIGHT. RITE AID CUSTOMERS LISTEN UP. YOU NOW HAVE UNTIL JUNE 6TH TO USE ANY GIFT CARDS, COUPONS, OR OTHER RITE AID REWARDS DUE TO THE COMPANY’S RECENT BANKRUPTCY ANNOUNCEMENT.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results